Loading organizations...
§ Private Profile · Tsur Moshe, HaMerkaz, Israel
Medical device manufacturer of biodegradable spacer technology for organ protection during cancer radiation therapy.
Based in Tzur Yigal, Israel, BioProtect manufactures biodegradable implantable balloon solutions designed to protect healthy organs from radiation damage during oncology treatments. The medical device manufacturer serves radiation therapy centers with its FDA-cleared spacer technology, which has been implanted in over 2,000 prostate cancer patients worldwide. Operating with 27 employees, the business generates 11 million 800 thousand dollars in annual revenue and has secured 30 million 200 thousand dollars in total venture capital funding. Its recent 28 million dollar Series C financing round was backed by institutional investors including MVM Partners, Peregrine Ventures, TriVentures, and Almeda Ventures. Founded in 2004 by Professor Avi Domb, Doctor Adrian Paz, and Shaul Shohat, and led by CEO Itay Barnea, the enterprise saw a strategic investor sign a memorandum of understanding to acquire it for 200 million dollars in January 2026.
BioProtect has raised $13.0M across 1 funding round.
BioProtect has raised $13.0M in total across 1 funding round.
BioProtect has raised $13.0M across 1 funding round. Most recently, it raised $13.0M Series D in January 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 15, 2020 | $13M Series D | Vincent Tchenguiz | Accelmed, KB Investment | Announced |
BioProtect has raised $13.0M in total across 1 funding round.
BioProtect's investors include Vincent Tchenguiz, Accelmed, KB Investment.